View Full Version : General Cancer News
- Mount Sinai Health System researchers present updates on cancer vaccine clinical tria
- Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primar
- Bankers Healthcare Group named one of Central New York's Best Places to Work
- Veritas Genetics introduces genetic screen for hereditary breast and ovarian cancer r
- New treatment option for postmenopausal women with non-invasive breast cancer
- Phase 2 results from Abbvie’s veliparib study in NSCLC presented at ASCO 2015
- ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors
- UC Santa Cruz-led study offers new insights into molecular mechanisms of biological c
- New FAU study sheds light on link between inflammation and cancer
- NCCN ORP and Pfizer IGLC collaborate to improve lives of people with metastatic breas
- Majority of breast cancer patients unaware of the effect of double mastectomy
- Genentech, Seragon, Regeneron and Avalanche receive Allicense 2015 Breakthrough Award
- New research draws on support from patients and public to investigate impact of cardi
- Breast surgery for low-grade ductal carcinoma in-situ may not change patients' surviv
- Novel strategy shows aptamer-based modular delivery of microRNA in endothelial, breas
- Wistar Institute scientists find new biomarker that appears to be more accurate at de
- New strategy involving three-pronged approach may keep lung cancer aside
- CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar
- Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured br
- PALOMA3 supports palbociclib use in advanced breast cancer
- University at Albany researcher receives $1.76 million NIH grant to explore role of v
- Findings could lead to new therapies that stop breast cancer progression
- New study shows that estrogen receptors vanish in cervical cancer tumors
- Pre-diagnostic short sleep duration, frequent snoring associated with poor cancer-spe
- BioNTech announces launch of MammaTyper test to improve breast cancer treatment
- MammaTyper molecular diagnostic test for breast cancer patients now available in Euro
- New gene mutations in ADAMTS family may contribute to outcomes in ovarian cancer
- USC Stem Cell scientist named 2015 Pew-Stewart scholar for cancer research
- Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs
- Daily dose of aspirin effective at blocking breast tumor growth
- Weill Cornell scientists reveal how XBP1 gene can trigger immune responses against ov
- Researchers discover new aspect of gene regulation
- Taiho, Servier sign exclusive license agreement to develop and commercialize TAS-102
- Study explores role of ALK1 protein in breast cancer metastasis
- Researchers identify gene variant that makes breast cancer cells more aggressive
- DAPK1 protein may be a promising new therapeutic target for most aggressive breast ca
- Nanoplatform technology that detects early stages of cancer receives U.S. patent
- ALK1 protein determines the extent of breast tumour's spread in the body
- Heparin market in Europe estimated to reach USD 3,148.0 million by 2022
- Simple test could help identify genetically inherited risk for prostate cancer
- Early menstrual cycle could play role in development of ER-negative breast cancer amo
- Researchers highlight important factors that impact early-stage breast cancer patient
- Study demonstrates potential of new approach for sorting out BRCA1 gene variants
- Study opens new area of discovery for different aspects of cell biology, biomedical r
- New Christian Doppler Laboratory for Clinical Molecular MR Imaging opens at MedUni Vi
- Hormones used in breast cancer treatment could affect disease progression, outcomes i
- Vaxil's ImMucin receives FDA orphan drug designation for treatment of multiple myelom
- Selective use of biomarker testing for breast cancer patients can save millions of do
- Steady rise in obesity, excess weight also signals upward swing in chronic health con
- Breast cancer treatment market estimated to increase to over $13.1 billion by 2020
- New device tracks chemical messages that regulate cell growth
- STAR tumor ablation system reduces pain from spinal tumors, improves quality of life
- Weight loss along with vitamin D supplementation reduces chronic inflammation
- E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder canc
- Weight loss, combined with vitamin D supplements, reduces chronic inflammation
- New Internet tool may help analyze genes based on their evolutionary profile
- High breast density can impact cancer screening methods
- Partial breast radiation after lumpectomy does not increase cancer recurrence
- The Mary Kay Foundation awards $1.3 million grant to advance cancer research and disc
- Scientists examine rates of secondary mutations in biomarker genes
- PharmaMar begins PM1183 phase III study in patients with platinum-resistant ovarian c
- New species of tRNA-derived small RNAs contribute to cell proliferation in cancer
- New York Blue Light Symposium highlights three measures to counter consequences of ar
- Aeterna Zentaris recruits patients for ZoptEC Phase 3 study in women with advanced en
- Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Ni
- Scientists identify new protein that affects growth of secondary breast tumours in th
- Nanoparticles packed with chemotherapy drug and coated with chitosan target cancer st
- Researchers map physical properties of live breast cancer cells using advanced AFM te
- Cancer Council Queensland urges women to be breast aware between scheduled screenings
- Mortality rates vary depending on socioeconomic differences among areas in Europe
- Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderat
- DTC genetic testing has negative consequences in children
- Researchers unravel mechanisms that enable accumulation of tumour promoting protease
- INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute
- 15-20% women are overdiagnosed in Norway's Breast Cancer Screening Programme
- New public guide addresses unrealistic expectations of screening tests
- UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive brea
- U-M researchers develop first-ever 3D model to help study treatment for pelvic organ
- Progesterone hormone can benefit breast cancer patients
- NSU cancer researcher selected for prestigious J. William Fulbright award
- Huntsman Cancer Institute receives NCI's Comprehensive Cancer Center designation
- UA researchers awarded NIH grant to develop software that lets doctors analyze digiti
- Dual breast exam using MRI and NIRST more accurate than MRI alone
- UMass Amherst scientist to study how estrogen-mimicking chemicals in the womb can inc
- KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhanc
- Study offers new way to suppress growth factors related to cancer cell proliferation
- University of Twente scientists take significant step in breast cancer research
- Cedars-Sinai's groundbreaking online registry improves participation in clinical rese
- New UW-Madison study links two unrelated cancer treatments
- Following restrictive sun exposure advice may be harmful to health
- USF College of Nursing awarded NCI grant to study mindfulness-based stress reduction
- Study examines how low-methionine diet may help improve outcomes in triple-negative b
- Women with low levels of anti-stress hormone at increased risk of getting breast canc
- Study: Breast cancer survivors experience post-treatment weight gain compared with ca
- Two chemical compounds effectively inhibit growth of brain cancer cells and breast tu
- Study shows that 14-3-3 sigma opposes, reverses tumor-promoting metabolic programs
- UT scientists develop system to map out the odds of breast cancer recurrence in indiv
- NeoGenomics announces launch of new germline cancer predisposition testing services
- Postmenopausal adiposity benefits with increasing aerobic exercise
- Breast cancer survivors in Appalachia not taking life-saving follow-up treatment, new
- State healthcare regulations linked to late-stage cancer diagnoses
- Tyrone Regional Health Network signs letter of intent to become member of Penn State
- UCLA's Jonsson Comprehensive Cancer Center named among top 10 cancer centers in natio
- Genetic variation influences survival in patients with multiple myeloma
- Additional radiation to surrounding lymph nodes provides added benefit to breast canc
- Deep Genomics set to bring the power of deep learning technologies to genomics
- Endocrine Society selects 18 endocrinologists as winners of 2016 Laureate Awards
- Case Western cancer researchers develop algorithm to detect DNA copy-number alteratio
- Study analyzes effect of shift work on prostate cancer
- New special issue addresses hottest areas of research in cancer and metabolism
- Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-1
- Lidocaine benefits breast cancer survivors who experience pain during intercourse
- Some breast cancer women can now undergo single-stage implant breast reconstruction
- Researchers gain new insight into the stages of breast cancer growth
- Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic
- BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medic
- Researchers quantify growth and composition of breast tumours in living animal
- BUSM researchers find new way to detect and treat basal-like breast cancer
- Oasmia announces topline results from head-to-head comparison study of Paclical and A
- EORTC study: Irradiation of regional nodes in breast cancer patients has marginal eff
- Molecular packaging enhances cancer drug’s effectiveness at destroying tumors
- CRI commits $29.3 million in new funds to accelerate development of cancer immunother
- Cancer survival in England remains lower compared to other countries with similar hea
- Genetic test may help identify better treatment option for HER2-positive breast cance
- Celsion reports updated results from HEAT Study of ThermoDox in patients with primary
- Newcastle University awarded £5M for drug development research
- Shorter course of whole breast radiation therapy better for women with early stage br
- CSN6 protein linked to poor survival among patients with colorectal cancer
- Barbara Ann Karmanos Cancer Institute, Wayne State University participate in NCI MATC
- Researcher study potential biomarker to determine patients at risk for aggressive bre
- New approach may offer improved way to detect early breast cancer
- Postmenopausal women more likely to use vaginal estrogen to achieve significantly hig
- Chances of survival due to chemotherapy significantly lower for older breast cancer p
- UNMCC receives NCI Comprehensive Cancer Center designation for cancer treatment, rese
- New MRI contrast agent detects tiny breast cancer tumors, micrometastases
- USF Health, FORCE receive $1.45 million from PCORI to advance and expand clinical res
- Researchers reveal cellular origin of PIK3CA-induced breast tumors
- Swarm intelligence can help to improve breast cancer screening
- Kentucky researcher awarded NCI grant to study potential link between obesity and bre
- Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women w
- Music therapy reduces anxiety in women undergoing surgical breast biopsies
- First patient enrolled in Phase II trial of ImmunoPulse IL-12 and pembrolizumab combi
- TapImmune announces successful conveyance of Investigational New Drug Application fro
- Researchers refine breast cancer risk model to give more accurate assessment
- EnGeneIC begins Phase 1 Tailored-EDV trial for advanced solid tumor
- Low, moderate alcohol intake elevates women’s risk of alcohol-related cancers
- Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer
- Low rate of mortality from breast cancer after DCIS diagnosis
- Esperance, MD Anderson form strategic alliance to accelerate development of anti-canc
- Regen BioPharma implements gene silencing technology in killing cancer stem cells
- Veritas Genetics obtains CE mark approval for myBRCA genetic screening test
- Karolinska Institutet study may lead to development of better immune-based cancer the
- Mayo Clinic scientists discover potential way to reprogram cancer cells back to norma
- Dr. Sharma receives research award from ASCO to continue study on triple-negative bre
- Study sheds light on fertility concerns of young breast cancer patients
- AirXpanders' pivotal XPAND trial meets primary endpoint in patients who have undergon
- Moffitt researchers discover high BRCA mutation frequency in young black women with b
- ASTRO awards $675,000 to seven physician-researchers to advance radiation oncology re
- Researchers report new optical method for quickly and accurately diagnosing breast ca
- Physical inactivity poses important clinical, public health and fiscal challenges for
- Cornell study reveals how obesity changes consistency of breast tissue
- New test predicts breast cancer relapse months in advance
- Genetic test that predicts recurrence of breast cancer may impact use of chemotherapy
- Fetal microchimerism could be a subtle and dizzyingly complex puzzle
- OU and Mercy receive $2.5 million grant to develop new short-term breast cancer risk
- Synthetic tissue environment enables spatial definition of cancer cells and macrophag
- Brain tumor is not always the death sentence
- Innovative research project explores impact of healthy weight and lifestyle in breast
- MACC1 gene can help predict better treatment options for patients with Klatskin carci
- UCSF-led team develops new technique to create tiny models of human tissues
- Affinity tuning can make CAR T cells spare normal cells and attack cancer cells
- New NIH grants support research that combines DNA sequence information and electronic
- Study reveals presence of new genetic mutation in melanoma cancer cells
- Double mastectomies on the rise in men with breast cancer, new report finds
- More men with breast cancer are opting for double mastectomy
- HUYA Bioscience International expands HBI-8000 clinical trials for breast cancer
- Acupuncture: A viable treatment for breast cancer survivors experiencing hot flashes
- Acupuncture may be a viable treatment for women experiencing hot flashes
- Free E-Book Offers Tips For Reducing Breast Cancer Risk At Nearly Any Age
- UCLA study questions the value of BRCA genetic testing in general population
- Oxis Biotech executes worldwide license agreement to develop, commercialize novel can
- Warwick Medical School to lead study on the effect of physiotherapy after breast canc
- New study examines effect of exercise on outcomes for older breast cancer survivors
- Offering women money to undergo mammograms ethically troubling, says Penn Medicine et
- Study finds breast cancer incidence, mortality rates are rising in low and middle inc
- A new approach to prevent breast and ovarian cancer
- UF Health Cancer Center — Orlando Health opens Cancer Genetics Center
- EMBL researchers use mass spectrometry data to analyze effects of cancer drugs
- Luteolin may reduce risk of breast cancer in some women, find MU researchers
- Research: Cancer preventative surgery may not be necessary in the future
- Researchers find key cellular enzyme that could be effective drug target for urologic
- NanoString announces key initiatives to expand market for nCounter Analysis System, r
- Researchers address challenges of effective universal health coverage focusing on car
- Scientists develop computational model to overcome misalignment of U.S. biomedical re
- Researchers establish link between bovine leukemia virus and human breast cancer
- Specific biomarker predicts which HER2-negative breast cancer patients respond to tar
- Gynaecological cancer still remains a taboo subject
- Cattle virus found in human cancer cells
- New report finds high proportion of advanced breast cancers in Cote d'Ivoire and Repu
- PharmaMar begins phase II 'Basket' trial to evaluate safety, efficacy of PM1183 in ad
- Manchester researchers reveal why ER+ breast cancer women develop resistance to hormo
- Artificial intelligence may improve outcomes in breast cancer patients
- CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy t
- NAMS recognizes outstanding contributions to the field of women's health, menopause
- Invitae launches new education program to increase awareness of genetic testing for h
- BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women w
- Researchers identify a protein that could potentially stop cancer
- Caring for women who develop invasive breast tumor in Germany
- Family history: The most vital risk factor for prostate cancer
- Paxman unveils commitment to ‘chase zero hair loss during chemotherapy’ at 2015 Europ
- UNC Lineberger earns 'exceptional' rating from NCI for major grant application
- NAMS panel provides recommendations to help women manage menopause-associated vasomot
- Innovative new device improves breast cancer treatment
- Study explores effectiveness of frontline treatments for couples with unexplained inf
- Scientists trace out intricate molecular pathway that may explain tamoxifen resistanc
- Research suggests potential drug targets to stop cancer spread
- New project aims to develop web-based tool for women considering CPM
- Arteries may be best source for detecting circulating tumor cells
- Re-engineering the brain to perceive food differently
- CrowdRise launches initiative that empowers people to change lives through crowdfundi
- Genetic mutations predict breast cancer relapse
- Hormonal therapy may protect women's ovaries, increase chances of pregnancy after bre
- Genomic Health announces presentation of two additional Oncotype DX clinical outcomes
- Multigene test performed on tumor can identify breast cancer patients who can safely
- Increasing availability of genetic tests for at-risk cancer patients
- Genetic test identifies breast cancer patients that can avoid chemotherapy and remain
- Scientists develop new molecular toolkit to investigate protein assemblies in human d
- Majority of cancer patients lack access to safe, affordable surgical care
- Tailorx trial data supports use of Oncotype DX test in patients with early stage brea
- Intratumoral morphological diversity of breast cancer not related to chromosome aberr
- ACR and SBI encourage women to get annual mammograms
- Leading cancer researchers address eight 'big questions'
- New review article discusses benefits, limitations of current screening mammography p
- Researchers roll out updated online breast cancer risk calculator
- Advanced targeted therapies dominate treatment pipeline for colorectal cancer, finds
- Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system
- Weight training can make a big difference for breast cancer survivors
- BCRF announces $48.5 million commitment to breast cancer research
- Preoperative MRI use increasing in breast cancer
- OBI Pharma transfers exclusive rights to develop, commercialize Dificid (fidaxomicin)
- GE unveils different breast cancer tests for different breasts
- Novel technique may help women and their oncologists choose options for treating brea
- UT Southwestern announces launch of new health initiative
- New online Smart Map shows progress in UK lung cancer care
- Researchers study effect of immune tolerance on certain cancer risks
- New studies suggest ways to improve cancer care by inhibiting oncogenes, boosting tum
- Scientists awarded £417,000 to develop a gel to advance breast cancer research, reduc
- Penn Medicine announces $375,000 in new grants to support BRCA-focused research proje
- Scientists identify culprit genes behind the formation and progression of breast tumo
- Endocrine Society issues Clinical Practice Guideline on treatment of menopausal sympt
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.